Cargando…
Repurposing drugs with specific activity against L-form bacteria
Cell wall deficient “L- form” bacteria are of growing medical interest as a possible source of recurrent or persistent infection, largely because of their complete resistance to cell wall active antibiotics such as β-lactams. Antibiotics that specifically kill L-forms would be of potential interest...
Autores principales: | Emami, Kaveh, Banks, Peter, Wu, Ling Juan, Errington, Jeffery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110866/ https://www.ncbi.nlm.nih.gov/pubmed/37082179 http://dx.doi.org/10.3389/fmicb.2023.1097413 |
Ejemplares similares
-
A Small Molecule Inhibitor of CTP Synthetase Identified by Differential Activity on a Bacillus subtilis Mutant Deficient in Class A Penicillin-Binding Proteins
por: Emami, Kaveh, et al.
Publicado: (2020) -
L-form bacteria, chronic diseases and the origins of life
por: Errington, Jeff, et al.
Publicado: (2016) -
Dissecting the roles of peptidoglycan synthetic and autolytic activities in the walled to L-form bacterial transition
por: Kawai, Yoshikazu, et al.
Publicado: (2023) -
L-form bacteria, cell walls and the origins of life
por: Errington, Jeff
Publicado: (2013) -
Amlodipine and lufenuron as repurposing drugs against Sporothrix brasiliensis
por: Poester, Vanice Rodrigues, et al.
Publicado: (2023)